SlideShare a Scribd company logo
1 of 4
Download to read offline
50
70
90
110
130
150
170
26/May/14
16/Jun/14
07/Jul/14
28/Jul/14
18/Aug/14
08/Sep/14
29/Sep/14
20/Oct/14
10/Nov/14
01/Dec/14
22/Dec/14
12/Jan/15
02/Feb/15
23/Feb/15
16/Mar/15
06/Apr/15
27/Apr/15
18/May/15
Kaveri Sensex
IndiaNivesh Research IndiaNivesh Securities Private Limited
601 & 602, Sukh Sagar, N. S. Patkar Marg, Girgaum Chowpatty, Mumbai 400 007. Tel: (022) 66188800
Result Update
May 27, 2015
Kaveri Seed Company Ltd. (KSCL)
IndiaNivesh Research
Daljeet S. Kohli
Head of Research
Tel: +91 22 66188826
daljeet.kohli@indianivesh.in
Amar Mourya
Research Analyst
Tel: +91 22 66188836
amar.mourya@indianivesh.in
IndiaNivesh Research is also available on Bloomberg INNS, Thomson First Call, Reuters and Factiva INDNIV.
CMP : Rs.831
Rating : HOLD
Target : Rs.908
Rating : BUY
Target : Rs.908
Current Previous
STOCK INFO
BSE 532,899
Nse KSCL
Index S&P BSE 200
Bloomberg KSCL IN
Reuters KVRI.BO
Sector Agri-Seed
Equity Capital (Rs mn) 137
Face Value (Rs) 2
Mkt Cap (Rs mn) 52,299
52w H/L (Rs) 1077/572
Avg Daily Vol (BSE+NSE) 209,384
SHAREHOLDING PATTERN %
(as on Mar. 2015)
Institutions 28.8
Others, Incl Public 13.6
Promoters 57.7
Source: BSE
STOCK PERFORMANCE (%) 1m 3m 12m
KAVERI -14 -7 28
SENSEX -1 -6 11
KAVERI v/s SENSEX
Source: Capitaline, IndiaNivesh Research
Source: Capitaline, IndiaNivesh Research
Downgraded to HOLD with unchanged TP of Rs.908
Rs.mn Q4FY15 Q3FY15 Q4FY14 Q‐o‐Q % Y‐o‐Y % Bloom est Variance(%) Comments
Revenue 399 907 392 -56.0% 1.9% 396 1% Above Est
EBIDTA 85 361 61 -76.6% 39.3% 60 42% Above Est
PAT 13 358 18 -96.5% -29.1% 49 -74% Below Est
Source: Company Filings; IndiaNivesh Research
 KSCL’s Q4FY15 result was mixed-bag; revenue and EBITDA above expectation;
PAT significantly below street estimates. In Q4FY15, revenue went up 1.9%
Y/Y to Rs.399 mn (v/s Bloom Est. Rs.396 mn). The key driver was lint and
other hybrid seed sales.
Standalone Seed‐Wise Revenue break‐up
(Rs Mn) FY13 FY14 FY15 Y/Y Ch %
Cotton 4200 6500 7610 17.1%
Corn 1250 1750 1600 -8.6%
Paddy 400 550 690 25.5%
All-Others 1010 983 1255 27.7%
Total 6860 9783 11155 14.0%
Source: Company Filings; IndiaNivesh Research
 During the quarter, EBITDA went-up 39.3% Y/Y to Rs.85 mn (v/s Bloom est:
Rs.60 mn) led by lower raw-material cost and reduction in employee
expenditure. EBITDA margin expanded 569 bps Y/Y to 21.2% (v/s Bloom est.
15.2%) due to higher realization per pack in Lint, Sunflower and Hybrid seeds.
The total operating expenditure (as % of revenue) stood at 78.8% (v/s 84.5%
in Q4FY14) led by lower material and employee cost; partially offset by higher
other expenditures.
 Depreciation during the quarter stood at Rs.84 mn (v/s Rs.45 mn in Q4FY14).
The company reported other income of Rs.49mn (v/s Rs.16 mn in Q4FY14).
Tax rate stood at 75% (v/s 4.2% in Q4FY14) leading to tax outgo of Rs.37 mn
(v/s Rs.13 mn in Q4FY14). As a result, PAT for the quarter went down 29.1%
y/y to Rs.13 mn (v/s Bloom est Rs.49 mn).
Key Conference Call Takeaway
Robust Outlook…
 The company reported revenue growth of 1.9% Y/Y to Rs.399 mn (v/s Rs.392
mn in Q4FY14). During the quarter, the total seed sale was Rs.290 mn (v/s
Rs.300 mn in Q4FY14). In FY15, the total seed sale went-up 14.0% Y/Y to
Rs.11.1 bn (v/s Rs.9.7 bn in FY14). The key drivers were Cotton (+17.1% Y/Y),
Paddy(+25.5%Y/Y)andothers(+27.7%Y/Y);partiallyoffsetby8.6%Y/Ydecline
in Corn (Maize) sales. The year gone by was very bad year for maize, more
than close to 15% decline was there in the acreages. According to
management, in FY16 Maize acreages is expected to see slight bounce back.
The outlook of other crops like rice and Bajra will also see improvement in
the market. Key markets for hybrid Maize would be Bihar, Karnataka,
Maharashtra, and Andhra Pradesh. Further, management expect huge growth
in hybrid Paddy demand on back of under penetration and new product
launch. Management intend to start commercial sales of genetically modified
cottonseedbyJun-2016.InFY16,themanagementexpect12-14%y/yincrease
in BT-cotton packet sales (1Pack = 450 grams) and +20% growth in Maize and
Rice. On back of strong growth and lower inventory in the system management
also expect increase in the realization during FY16.
IndiaNivesh Research Kaveri Seed Company Ltd| Result Update
Result Update (contd...)
May 27, 2015 | 2
Favourable Cotton Scenario…
 The company received advances of Rs.2,250 mn (v/s Rs.2,350 in Q4FY14). As
a result, management does not see any major reduction in the cotton acreages
in FY16. Management expect increase in cotton acreages in areas like Andhra,
Karnataka, and Maharashtra, whereas expect decrease (10-15%) in the
Northern areas. The company also expect increase in the cotton market share
from 20% to 25% in the key areas going-ahead. On account of significant
decline in commodity prices like Soya (down 40%) relative to Cotton (down
30%), the overall agronomics looks positive for BT-cotton.
Other conference call highlights
 Management expects corn seed industry volumes to increase to 150,000 MT
within the next five years from 100,000 MT currently. The hybridization rate
in corn still stands at only 55-60%, leaving ample opportunity for growth.
KSCL expects to increase its own market share from 12% currently to 15-16%
over this timeframe.
 The marketfor hybrid paddy is expected to grow multi-fold from 2.5m hectares
currently to 5-7m hectares within the next five years. The hybridization rate
in paddy remains only ~5%, indicating a vast growth opportunity. KSCL is very
confident of increasing its market share in hybrid paddy, and projected 30%+
growth in this segment for FY15.
 Management sees a fair chance of an increase in cotton seed prices by FY16
due to mismatch in demand and inventory availability. KSCL itself is cutting
down its own production substantially for next year (considering its inventory
balance), and measures like these could help reduce the inventory overhang
in the industry. The company’s management expect to increase its cotton
market share from 20% (9.6 mn pack) to ~25% (12.5 mn pack) in next three
years.
 The company hired the new CEO in order grow the exports business over a
period of 3-4 years.
 Management forecast Rs.1500 mn of capex (Rs.400-500 mn /yearly) for next
three years on following: (1) construction of warehouse for paddy in AP, and
(2) R&D investment in Bio-technology (Rs.200-250 mn/yearly). The company
has total cash balance of Rs.3,013 mn as on 31/3/2015.
Valuation
At CMP of Rs.831, the stock is trading at P/E multiple of 15.2x FY16E and 12.1x
FY17E based on Bloomberg consensus earnings. On back of solid industry
fundamentals the macro outlook for hybrid seed industry looks attractive over
medium-term. Additionally, KSCL’s strong industry position, wide distribution
network, diversified product range, superior R&D capabilities places it well to benefit
from large macro opportunities in sector. However, given the limited upside from
our previous target price to Rs.908 (13.3x FY17E earnings) we downgrade our rating
to HOLD from BUY on stock.
IndiaNivesh Research Kaveri Seed Company Ltd| Result Update
Result Update (contd...)
May 27, 2015 | 3
Kaveri Seed Company Ltd (Rs in Mn.)
(Conso.) Q4FY14 Q3FY15 Q4FY15 Q/Q % Y/Y % FY15 FY14 Y/Y %
Net Sales 392 907 399 -56.0 1.9 11612 10,111 14.8
Other Operating Income 0 0 0 NM NM 0 - NM
Total Income 392 907 399 -56.0 1.9 11612 10,111 14.8
0
Cost of Material 1846 267 2320 770.0 25.7 4219 3,813 10.7
Purchase of stock in trade 0 0 0 NM NM 0 -61 -100.0
Change in inventory -1649 38 -2130 -5719.3 29.2 165 282 -41.5
Employee Benefit Exp 78 73 63 -14.1 -19.5 309 3,866 -92.0
Other Exp 56 168 62 -63.1 10.5 3822 - NM
Total Expenditure 331 546 315 ‐42.3 ‐5.0 8515 7,899 7.8
PBIDT 61 361 85 -76.6 39.3 3097 2,212 40.0
Interest 1 1 0 -38.6 -72.2 2 2 -29.5
PBDT 60 360 84 -76.6 41.5 3095 2210 40.1
0
Depreciation 45 22 84 282.2 85.2 149 164 -9.3
Other Income 16 25 49 94.8 212.2 157 97 61.4
Minority Interest Before NP 0 0 NM NM 0 -
PBT 30 363 49 -86.5 64.5 3104 2,143 44.8
0
Tax 13 5 37 634.0 191.3 92 52 79.0
Reported Profit After Tax 17 358 13 -96.5 -27.7 3012 2,092 44.0
Minority Interest After NP 0 0 -3 -962.9 639.1 -2 2 NM
Profit/Loss of Associate Company 0 0 0 NM NM 0 - NM
Net Profit after Minority Interest & P/L Asso.Co. 18 358 16 -95.6 -10.5 3013 2,090 NM
Extra-ordinary Items 0 0 3 NM NM 3 - NM
Adjusted Profit After Extra‐ordinary item 18 358 13 -96.5 -29.1 3010 2090 44.0
O/Shares 69 69 69 0.0 0.0 69 69 0.0
EPS (Unit Curr.) 0.3 5.2 0.2 -96.5 -29.1 43.6 30.3 44.0
EBIDTM(%) 15.5 39.8 21.2 -1862 569 26.7 21.9 121.9
PATM(%) 4.5 39.5 3.2 -3632 -138 25.9 20.7 125.4
Source: Company Filings; IndiaNivesh Research
IndiaNivesh Research Kaveri Seed Company Ltd| Result Update
Result Update (contd...)
May 27, 2015 | 4
IndiaNivesh Research is also available on Bloomberg INNS, Thomson First Call, Reuters and Factiva INDNIV.
IndiaNivesh Securities Private Limited
601 & 602, Sukh Sagar, N. S. Patkar Marg, Girgaum Chowpatty, Mumbai 400 007.
Tel: (022) 66188800 / Fax: (022) 66188899
e-mail: research@indianivesh.in | Website: www.indianivesh.in
Disclaimer: This document has been prepared by IndiaNivesh Securities Private Limited (“INSPL”), for use by the recipient as information only and is not for circulation or public distribution. INSPL includes
subsidiaries, group and associate companies, promoters, employees and affiliates. INSPL researches, aggregates and faithfully reproduces information available in public domain and other sources, considered
to be reliable and makes them available for the recipient, though its accuracy or completeness has not been verified by INSPL independently and cannot be guaranteed. The third party research material included
in this document does not represent the views of INSPL and/or its officers, employees and the recipient must exercise independent judgement with regard to such content. This document has been published in
accordance with the provisions of Regulation 18 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. This document is not to be altered, transmitted, reproduced, copied,
redistributed, uploaded or published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from INSPL. This document is solely for information purpose
and should not to be construed as an offer to sell or the solicitation of an offer to buy any security. Recipients of this document should be aware that past performance is not necessarily a guide for future
performance and price and value of investments can go up or down. The suitability or otherwise of any investments will depend upon the recipients particular circumstances. INSPL does not take responsibility
thereof. The research analysts of INSPL have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. This document is based
on technical and derivative analysis center on studying charts of a stock’s price movement, outstanding positions and trading volume, as opposed to focusing on a company’s fundamentals and, as such, may not
match with a report on a company’s fundamentals. Nothing in this document constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or
appropriate to recipients’ specific circumstances. INSPL does not accept any responsibility or whatever nature for the information, assurances, statements and opinion given, made available or expressed herein
or for any omission or for any liability arising from the use of this document. Opinions expressed are our current opinions as of the date appearing on this document only. The opinions are subject to change
without any notice. INSPL directors/employees and its clients may have holdings in the stocks mentioned in the document.
This report is based / focused on fundamentals of the Company and forward-looking statements as such, may not match with a report on a company’s technical analysis report
Each of the analysts named below hereby certifies that, with respect to each subject company and its securities for which the analyst is responsible in this report, (1) all of the views expressed in this report
accurately reflect his or her personal views about the subject companies and securities, and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations
or views expressed in this report: Daljeet S Kohli, Amar Maurya, Abhishek Jain, Yogesh Hotwani, Prerna Jhunjhunwala, Kaushal Patel, Rahul Koli, Tushar Manudhane & Dharmesh Kant.
Following table contains the disclosure of interest in order to adhere to utmost transparency in the matter:
INSPL, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictoryto the recommendations expressed
herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law,
without any prior notice. INSPL reserves the right to make modifications and alternations to this statement, as may be required, from time to time.
Definitions of ratings
BUY. We expect this stock to deliver more than 15% returns over the next 12 months.
HOLD. We expect this stock to deliver -15% to +15% returns over the next 12 months.
SELL. We expect this stock to deliver <-15% returns over the next 12 months.
Our target prices are on a 12-month horizon basis.
Other definitions
NR = Not Rated. The investment rating and target price, if any, have been arrived at due to certain circumstances not in control of INSPL
CS = Coverage Suspended. INSPL has suspended coverage of this company.
UR=Under Review. Such e invest review happens when any developments have already occurred or likely to occur in target company & INSPL analyst is waiting for some more information to draw conclusion on
rating/target.
NA = Not Available or Not Applicable. The information is not available for display or is not applicable.
NM = Not Meaningful. The information is not meaningful and is therefore excluded.
Research Analyst has not served as an officer, director or employee of Subject Company
One year Price history of the daily closing price of the securities covered in this note is available at www.nseindia.com and www.economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose name of
company in the list browse companies and select 1 year in icon YTD in the price chart)
Home
Disclosure of Interest Statement
1. Details of business activity of IndiaNivesh Securities Private Limited (INSPL) INSPL is a Stock Broker registered with BSE, NSE and MCX - SX in all the major segments viz. Cash, F & O and
CDS segments. INSPL is also a Depository Participant and registered with both Depository viz. CDSL and NSDL.
Further, INSPL is a Registered Portfolio Manager and is registered with SEBI.
2. Details of Disciplinary History of INSPL No disciplinary action is / was running / initiated against INSPL
3. Details of Associates of INSPL
4. Research analyst or INSPL or its relatives'/associates' financial interest in the subject No (except to the extent of shares held by Research analyst or INSPL or its relatives'/associates')
company and nature of such financial interest
5. Research analyst or INSPL or its relatives'/associates' actual/beneficial ownership of 1% or more
in securities of the subject company, at the end of the month immediately preceding the date
of publication of the document.
6. Research analyst or INSPL or its relatives'/associates' any other material conflict of interest
at the time of publication of the document No
7. Has research analyst or INSPL or its associates received any compensation from the subject
company in the past 12 months No
8. Has research analyst or INSPL or its associates managed or co-managed public offering of
securities for the subject company in the past 12 months No
9. Has research analyst or INSPL or its associates received any compensation for investment banking
or merchant banking or brokerage services from the subject company in the past 12 months No
10. Has research analyst or INSPL or its associates received any compensation for products or services
other than investment banking or merchant banking or brokerage services from the subject
company in the past 12 months No
11. Has research analyst or INSPL or its associates received any compensation or other benefits
from the subject company or third party in connection with the document. No
12. Has research analyst served as an officer, director or employee of the subject company No
13. Has research analyst or INSPL engaged in market making activity for the subject company No
14. Other disclosures No
Please refer to the important 'Stock Holding Disclosure' report on the IndiaNivesh website (investment
Research Section -
http://www.indianivesh.in/Research/Holding_Disclosure.aspx?id=10link).
Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks.
INSPL and its affiliates may have investment positions in the stocks recommended in this report.
Please refer to the important 'Stock Holding Disclosure' report on the IndiaNivesh website (investment
Research Section -
http://www.indianivesh.in/Research/Holding_Disclosure.aspx?id=10link).
Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks.
INSPL and its affiliates may have investment positions in the stocks recommended in this report.

More Related Content

What's hot

Epic research daily agri report 19th feb 2016
Epic research daily agri report 19th feb 2016Epic research daily agri report 19th feb 2016
Epic research daily agri report 19th feb 2016Epic Research Limited
 
Epic research daily agri report 25th may 2016
Epic research daily agri report 25th may 2016Epic research daily agri report 25th may 2016
Epic research daily agri report 25th may 2016Epic Research
 
working capital
working capitalworking capital
working capitalsimmy2
 
Nandan exim research report
Nandan exim research reportNandan exim research report
Nandan exim research reportFirststepcapital
 
FINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG- FOOD SECTOR
FINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG-FOOD SECTORFINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG-FOOD SECTOR
FINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG- FOOD SECTORAnkita Kamble
 
Epic research daily agri report 29 sept 2015
Epic research daily agri report 29 sept 2015Epic research daily agri report 29 sept 2015
Epic research daily agri report 29 sept 2015Epic Research Limited
 
Epic research daily agri report 29th feb 2016
Epic research daily agri report 29th feb 2016Epic research daily agri report 29th feb 2016
Epic research daily agri report 29th feb 2016Epic Research Limited
 
Epic research daily agri report 18 feb 2015
Epic research daily agri report  18 feb 2015Epic research daily agri report  18 feb 2015
Epic research daily agri report 18 feb 2015Epic Research Limited
 
a report of NISHAT MILLS PAKISTAN
a report of NISHAT MILLS PAKISTANa report of NISHAT MILLS PAKISTAN
a report of NISHAT MILLS PAKISTANMohammad Salman
 
Investment desicions agrochemical sector
Investment desicions   agrochemical sectorInvestment desicions   agrochemical sector
Investment desicions agrochemical sectorShefaliSatija1
 
Epic research daily agri report 29 jan 2016
Epic research daily agri report 29 jan 2016Epic research daily agri report 29 jan 2016
Epic research daily agri report 29 jan 2016Epic Research Limited
 
Epic research daily agri report 22 july 2015
Epic research  daily agri report 22 july  2015Epic research  daily agri report 22 july  2015
Epic research daily agri report 22 july 2015Epic Research Limited
 
Export rice presentation
Export rice presentationExport rice presentation
Export rice presentation915738
 
Epic research daily agri report 19 jan 2015
Epic research daily agri report  19 jan 2015Epic research daily agri report  19 jan 2015
Epic research daily agri report 19 jan 2015Epic Research Limited
 
Epic research daily agri report 20 oct 2015
Epic research daily agri report 20 oct 2015Epic research daily agri report 20 oct 2015
Epic research daily agri report 20 oct 2015Epic Research Limited
 
Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...
Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...
Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...Ajjay Kumar Gupta
 
A project report on financial appriasal in diversification project at the ug...
A project report on  financial appriasal in diversification project at the ug...A project report on  financial appriasal in diversification project at the ug...
A project report on financial appriasal in diversification project at the ug...Babasab Patil
 
Project presentation finance technocraft ind
Project presentation finance technocraft indProject presentation finance technocraft ind
Project presentation finance technocraft indAnandhu PS
 

What's hot (20)

Epic research daily agri report 19th feb 2016
Epic research daily agri report 19th feb 2016Epic research daily agri report 19th feb 2016
Epic research daily agri report 19th feb 2016
 
Epic research daily agri report 25th may 2016
Epic research daily agri report 25th may 2016Epic research daily agri report 25th may 2016
Epic research daily agri report 25th may 2016
 
working capital
working capitalworking capital
working capital
 
Nandan exim research report
Nandan exim research reportNandan exim research report
Nandan exim research report
 
FINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG- FOOD SECTOR
FINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG-FOOD SECTORFINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG-FOOD SECTOR
FINANCIAL PERFORMANCE ANALYSIS OF ITC, BRITANNIA, CADBURY IN FMCG- FOOD SECTOR
 
Epic research daily agri report 29 sept 2015
Epic research daily agri report 29 sept 2015Epic research daily agri report 29 sept 2015
Epic research daily agri report 29 sept 2015
 
Epic research daily agri report 29th feb 2016
Epic research daily agri report 29th feb 2016Epic research daily agri report 29th feb 2016
Epic research daily agri report 29th feb 2016
 
Epic research daily agri report 18 feb 2015
Epic research daily agri report  18 feb 2015Epic research daily agri report  18 feb 2015
Epic research daily agri report 18 feb 2015
 
a report of NISHAT MILLS PAKISTAN
a report of NISHAT MILLS PAKISTANa report of NISHAT MILLS PAKISTAN
a report of NISHAT MILLS PAKISTAN
 
Investment desicions agrochemical sector
Investment desicions   agrochemical sectorInvestment desicions   agrochemical sector
Investment desicions agrochemical sector
 
Epic research daily agri report 29 jan 2016
Epic research daily agri report 29 jan 2016Epic research daily agri report 29 jan 2016
Epic research daily agri report 29 jan 2016
 
5 growth stocks 24-04-16
5 growth stocks 24-04-165 growth stocks 24-04-16
5 growth stocks 24-04-16
 
Epic research daily agri report 22 july 2015
Epic research  daily agri report 22 july  2015Epic research  daily agri report 22 july  2015
Epic research daily agri report 22 july 2015
 
Export rice presentation
Export rice presentationExport rice presentation
Export rice presentation
 
Epic research daily agri report 19 jan 2015
Epic research daily agri report  19 jan 2015Epic research daily agri report  19 jan 2015
Epic research daily agri report 19 jan 2015
 
Epic research daily agri report 20 oct 2015
Epic research daily agri report 20 oct 2015Epic research daily agri report 20 oct 2015
Epic research daily agri report 20 oct 2015
 
Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...
Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...
Poultry and Broiler Farming - Manufacturing Plant, Detailed Project Report, P...
 
Relevance of Futures for Indian Oil & Oilseed Industry
Relevance of Futures for Indian Oil & Oilseed IndustryRelevance of Futures for Indian Oil & Oilseed Industry
Relevance of Futures for Indian Oil & Oilseed Industry
 
A project report on financial appriasal in diversification project at the ug...
A project report on  financial appriasal in diversification project at the ug...A project report on  financial appriasal in diversification project at the ug...
A project report on financial appriasal in diversification project at the ug...
 
Project presentation finance technocraft ind
Project presentation finance technocraft indProject presentation finance technocraft ind
Project presentation finance technocraft ind
 

Similar to Kaveri Seed: IndiaNivesh downgrade to 'Hold' after mixed-bag Q4FY15 results

Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Angel Broking
 
Buy Bata India for a target of Rs1180 by Motilal Oswal
Buy Bata India for a target of Rs1180 by Motilal OswalBuy Bata India for a target of Rs1180 by Motilal Oswal
Buy Bata India for a target of Rs1180 by Motilal OswalIndiaNotes.com
 
Motilal wonderla 02_feb15
Motilal wonderla 02_feb15Motilal wonderla 02_feb15
Motilal wonderla 02_feb15IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Q3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideQ3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideIndiaNotes.com
 
CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
 CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
CCL Products: Standalone net sales grew by 4.2% y-o-y; AccumulateIndiaNotes.com
 
Arvnd 20150205-mosl-ru-pg014
Arvnd 20150205-mosl-ru-pg014Arvnd 20150205-mosl-ru-pg014
Arvnd 20150205-mosl-ru-pg014Jigar Savla
 
Trident - Elara Securities - 18 December 2014 (1)
Trident - Elara Securities - 18 December 2014 (1)Trident - Elara Securities - 18 December 2014 (1)
Trident - Elara Securities - 18 December 2014 (1)Kimi Walia
 
SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016
SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016
SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016SBI Mutual Fund
 
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsBuy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsIndiaNotes.com
 
PI Industries: Another strong performance; Sales up 16% in Q1FY15
 PI Industries: Another strong performance; Sales up 16% in Q1FY15 PI Industries: Another strong performance; Sales up 16% in Q1FY15
PI Industries: Another strong performance; Sales up 16% in Q1FY15IndiaNotes.com
 
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'IndiaNotes.com
 
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yFirstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yIndiaNotes.com
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyIndiaNotes.com
 
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherBuy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherIndiaNotes.com
 
Firstcall recommends a textile stock for the mid- to long-term
Firstcall recommends a textile stock for the mid- to long-termFirstcall recommends a textile stock for the mid- to long-term
Firstcall recommends a textile stock for the mid- to long-termIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 

Similar to Kaveri Seed: IndiaNivesh downgrade to 'Hold' after mixed-bag Q4FY15 results (20)

Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010
 
Buy Bata India for a target of Rs1180 by Motilal Oswal
Buy Bata India for a target of Rs1180 by Motilal OswalBuy Bata India for a target of Rs1180 by Motilal Oswal
Buy Bata India for a target of Rs1180 by Motilal Oswal
 
Motilal wonderla 02_feb15
Motilal wonderla 02_feb15Motilal wonderla 02_feb15
Motilal wonderla 02_feb15
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Se quent press release q3fy20
Se quent press release q3fy20Se quent press release q3fy20
Se quent press release q3fy20
 
Q3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideQ3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upside
 
CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
 CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate
 
Arvnd 20150205-mosl-ru-pg014
Arvnd 20150205-mosl-ru-pg014Arvnd 20150205-mosl-ru-pg014
Arvnd 20150205-mosl-ru-pg014
 
Trident - Elara Securities - 18 December 2014 (1)
Trident - Elara Securities - 18 December 2014 (1)Trident - Elara Securities - 18 December 2014 (1)
Trident - Elara Securities - 18 December 2014 (1)
 
SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016
SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016
SBI Magnum Equity Fund: An Equity Mutual Fund - Apr 2016
 
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsBuy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
 
PI Industries: Another strong performance; Sales up 16% in Q1FY15
 PI Industries: Another strong performance; Sales up 16% in Q1FY15 PI Industries: Another strong performance; Sales up 16% in Q1FY15
PI Industries: Another strong performance; Sales up 16% in Q1FY15
 
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
 
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yFirstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
 
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherBuy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
 
Firstcall recommends a textile stock for the mid- to long-term
Firstcall recommends a textile stock for the mid- to long-termFirstcall recommends a textile stock for the mid- to long-term
Firstcall recommends a textile stock for the mid- to long-term
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNotes.com
 
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesIndiaNotes.com
 
Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15IndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
 
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
 
Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15
 

Recently uploaded

Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...makika9823
 
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证jdkhjh
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designsegoetzinger
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyTyöeläkeyhtiö Elo
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...Suhani Kapoor
 
House of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHouse of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHenry Tapper
 
Bladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Roomdivyansh0kumar0
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawlmakika9823
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdfAdnet Communications
 
Vp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsAppVp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsAppmiss dipika
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Roomdivyansh0kumar0
 
Attachment Of Assets......................
Attachment Of Assets......................Attachment Of Assets......................
Attachment Of Assets......................AmanBajaj36
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办fqiuho152
 
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130Suhani Kapoor
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证rjrjkk
 
How Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of ReportingHow Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of ReportingAggregage
 

Recently uploaded (20)

Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
 
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designs
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
 
House of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHouse of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview document
 
Bladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results Presentation
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf
 
Vp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsAppVp Girls near me Delhi Call Now or WhatsApp
Vp Girls near me Delhi Call Now or WhatsApp
 
Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
 
Attachment Of Assets......................
Attachment Of Assets......................Attachment Of Assets......................
Attachment Of Assets......................
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
 
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
 
How Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of ReportingHow Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of Reporting
 

Kaveri Seed: IndiaNivesh downgrade to 'Hold' after mixed-bag Q4FY15 results

  • 1. 50 70 90 110 130 150 170 26/May/14 16/Jun/14 07/Jul/14 28/Jul/14 18/Aug/14 08/Sep/14 29/Sep/14 20/Oct/14 10/Nov/14 01/Dec/14 22/Dec/14 12/Jan/15 02/Feb/15 23/Feb/15 16/Mar/15 06/Apr/15 27/Apr/15 18/May/15 Kaveri Sensex IndiaNivesh Research IndiaNivesh Securities Private Limited 601 & 602, Sukh Sagar, N. S. Patkar Marg, Girgaum Chowpatty, Mumbai 400 007. Tel: (022) 66188800 Result Update May 27, 2015 Kaveri Seed Company Ltd. (KSCL) IndiaNivesh Research Daljeet S. Kohli Head of Research Tel: +91 22 66188826 daljeet.kohli@indianivesh.in Amar Mourya Research Analyst Tel: +91 22 66188836 amar.mourya@indianivesh.in IndiaNivesh Research is also available on Bloomberg INNS, Thomson First Call, Reuters and Factiva INDNIV. CMP : Rs.831 Rating : HOLD Target : Rs.908 Rating : BUY Target : Rs.908 Current Previous STOCK INFO BSE 532,899 Nse KSCL Index S&P BSE 200 Bloomberg KSCL IN Reuters KVRI.BO Sector Agri-Seed Equity Capital (Rs mn) 137 Face Value (Rs) 2 Mkt Cap (Rs mn) 52,299 52w H/L (Rs) 1077/572 Avg Daily Vol (BSE+NSE) 209,384 SHAREHOLDING PATTERN % (as on Mar. 2015) Institutions 28.8 Others, Incl Public 13.6 Promoters 57.7 Source: BSE STOCK PERFORMANCE (%) 1m 3m 12m KAVERI -14 -7 28 SENSEX -1 -6 11 KAVERI v/s SENSEX Source: Capitaline, IndiaNivesh Research Source: Capitaline, IndiaNivesh Research Downgraded to HOLD with unchanged TP of Rs.908 Rs.mn Q4FY15 Q3FY15 Q4FY14 Q‐o‐Q % Y‐o‐Y % Bloom est Variance(%) Comments Revenue 399 907 392 -56.0% 1.9% 396 1% Above Est EBIDTA 85 361 61 -76.6% 39.3% 60 42% Above Est PAT 13 358 18 -96.5% -29.1% 49 -74% Below Est Source: Company Filings; IndiaNivesh Research  KSCL’s Q4FY15 result was mixed-bag; revenue and EBITDA above expectation; PAT significantly below street estimates. In Q4FY15, revenue went up 1.9% Y/Y to Rs.399 mn (v/s Bloom Est. Rs.396 mn). The key driver was lint and other hybrid seed sales. Standalone Seed‐Wise Revenue break‐up (Rs Mn) FY13 FY14 FY15 Y/Y Ch % Cotton 4200 6500 7610 17.1% Corn 1250 1750 1600 -8.6% Paddy 400 550 690 25.5% All-Others 1010 983 1255 27.7% Total 6860 9783 11155 14.0% Source: Company Filings; IndiaNivesh Research  During the quarter, EBITDA went-up 39.3% Y/Y to Rs.85 mn (v/s Bloom est: Rs.60 mn) led by lower raw-material cost and reduction in employee expenditure. EBITDA margin expanded 569 bps Y/Y to 21.2% (v/s Bloom est. 15.2%) due to higher realization per pack in Lint, Sunflower and Hybrid seeds. The total operating expenditure (as % of revenue) stood at 78.8% (v/s 84.5% in Q4FY14) led by lower material and employee cost; partially offset by higher other expenditures.  Depreciation during the quarter stood at Rs.84 mn (v/s Rs.45 mn in Q4FY14). The company reported other income of Rs.49mn (v/s Rs.16 mn in Q4FY14). Tax rate stood at 75% (v/s 4.2% in Q4FY14) leading to tax outgo of Rs.37 mn (v/s Rs.13 mn in Q4FY14). As a result, PAT for the quarter went down 29.1% y/y to Rs.13 mn (v/s Bloom est Rs.49 mn). Key Conference Call Takeaway Robust Outlook…  The company reported revenue growth of 1.9% Y/Y to Rs.399 mn (v/s Rs.392 mn in Q4FY14). During the quarter, the total seed sale was Rs.290 mn (v/s Rs.300 mn in Q4FY14). In FY15, the total seed sale went-up 14.0% Y/Y to Rs.11.1 bn (v/s Rs.9.7 bn in FY14). The key drivers were Cotton (+17.1% Y/Y), Paddy(+25.5%Y/Y)andothers(+27.7%Y/Y);partiallyoffsetby8.6%Y/Ydecline in Corn (Maize) sales. The year gone by was very bad year for maize, more than close to 15% decline was there in the acreages. According to management, in FY16 Maize acreages is expected to see slight bounce back. The outlook of other crops like rice and Bajra will also see improvement in the market. Key markets for hybrid Maize would be Bihar, Karnataka, Maharashtra, and Andhra Pradesh. Further, management expect huge growth in hybrid Paddy demand on back of under penetration and new product launch. Management intend to start commercial sales of genetically modified cottonseedbyJun-2016.InFY16,themanagementexpect12-14%y/yincrease in BT-cotton packet sales (1Pack = 450 grams) and +20% growth in Maize and Rice. On back of strong growth and lower inventory in the system management also expect increase in the realization during FY16.
  • 2. IndiaNivesh Research Kaveri Seed Company Ltd| Result Update Result Update (contd...) May 27, 2015 | 2 Favourable Cotton Scenario…  The company received advances of Rs.2,250 mn (v/s Rs.2,350 in Q4FY14). As a result, management does not see any major reduction in the cotton acreages in FY16. Management expect increase in cotton acreages in areas like Andhra, Karnataka, and Maharashtra, whereas expect decrease (10-15%) in the Northern areas. The company also expect increase in the cotton market share from 20% to 25% in the key areas going-ahead. On account of significant decline in commodity prices like Soya (down 40%) relative to Cotton (down 30%), the overall agronomics looks positive for BT-cotton. Other conference call highlights  Management expects corn seed industry volumes to increase to 150,000 MT within the next five years from 100,000 MT currently. The hybridization rate in corn still stands at only 55-60%, leaving ample opportunity for growth. KSCL expects to increase its own market share from 12% currently to 15-16% over this timeframe.  The marketfor hybrid paddy is expected to grow multi-fold from 2.5m hectares currently to 5-7m hectares within the next five years. The hybridization rate in paddy remains only ~5%, indicating a vast growth opportunity. KSCL is very confident of increasing its market share in hybrid paddy, and projected 30%+ growth in this segment for FY15.  Management sees a fair chance of an increase in cotton seed prices by FY16 due to mismatch in demand and inventory availability. KSCL itself is cutting down its own production substantially for next year (considering its inventory balance), and measures like these could help reduce the inventory overhang in the industry. The company’s management expect to increase its cotton market share from 20% (9.6 mn pack) to ~25% (12.5 mn pack) in next three years.  The company hired the new CEO in order grow the exports business over a period of 3-4 years.  Management forecast Rs.1500 mn of capex (Rs.400-500 mn /yearly) for next three years on following: (1) construction of warehouse for paddy in AP, and (2) R&D investment in Bio-technology (Rs.200-250 mn/yearly). The company has total cash balance of Rs.3,013 mn as on 31/3/2015. Valuation At CMP of Rs.831, the stock is trading at P/E multiple of 15.2x FY16E and 12.1x FY17E based on Bloomberg consensus earnings. On back of solid industry fundamentals the macro outlook for hybrid seed industry looks attractive over medium-term. Additionally, KSCL’s strong industry position, wide distribution network, diversified product range, superior R&D capabilities places it well to benefit from large macro opportunities in sector. However, given the limited upside from our previous target price to Rs.908 (13.3x FY17E earnings) we downgrade our rating to HOLD from BUY on stock.
  • 3. IndiaNivesh Research Kaveri Seed Company Ltd| Result Update Result Update (contd...) May 27, 2015 | 3 Kaveri Seed Company Ltd (Rs in Mn.) (Conso.) Q4FY14 Q3FY15 Q4FY15 Q/Q % Y/Y % FY15 FY14 Y/Y % Net Sales 392 907 399 -56.0 1.9 11612 10,111 14.8 Other Operating Income 0 0 0 NM NM 0 - NM Total Income 392 907 399 -56.0 1.9 11612 10,111 14.8 0 Cost of Material 1846 267 2320 770.0 25.7 4219 3,813 10.7 Purchase of stock in trade 0 0 0 NM NM 0 -61 -100.0 Change in inventory -1649 38 -2130 -5719.3 29.2 165 282 -41.5 Employee Benefit Exp 78 73 63 -14.1 -19.5 309 3,866 -92.0 Other Exp 56 168 62 -63.1 10.5 3822 - NM Total Expenditure 331 546 315 ‐42.3 ‐5.0 8515 7,899 7.8 PBIDT 61 361 85 -76.6 39.3 3097 2,212 40.0 Interest 1 1 0 -38.6 -72.2 2 2 -29.5 PBDT 60 360 84 -76.6 41.5 3095 2210 40.1 0 Depreciation 45 22 84 282.2 85.2 149 164 -9.3 Other Income 16 25 49 94.8 212.2 157 97 61.4 Minority Interest Before NP 0 0 NM NM 0 - PBT 30 363 49 -86.5 64.5 3104 2,143 44.8 0 Tax 13 5 37 634.0 191.3 92 52 79.0 Reported Profit After Tax 17 358 13 -96.5 -27.7 3012 2,092 44.0 Minority Interest After NP 0 0 -3 -962.9 639.1 -2 2 NM Profit/Loss of Associate Company 0 0 0 NM NM 0 - NM Net Profit after Minority Interest & P/L Asso.Co. 18 358 16 -95.6 -10.5 3013 2,090 NM Extra-ordinary Items 0 0 3 NM NM 3 - NM Adjusted Profit After Extra‐ordinary item 18 358 13 -96.5 -29.1 3010 2090 44.0 O/Shares 69 69 69 0.0 0.0 69 69 0.0 EPS (Unit Curr.) 0.3 5.2 0.2 -96.5 -29.1 43.6 30.3 44.0 EBIDTM(%) 15.5 39.8 21.2 -1862 569 26.7 21.9 121.9 PATM(%) 4.5 39.5 3.2 -3632 -138 25.9 20.7 125.4 Source: Company Filings; IndiaNivesh Research
  • 4. IndiaNivesh Research Kaveri Seed Company Ltd| Result Update Result Update (contd...) May 27, 2015 | 4 IndiaNivesh Research is also available on Bloomberg INNS, Thomson First Call, Reuters and Factiva INDNIV. IndiaNivesh Securities Private Limited 601 & 602, Sukh Sagar, N. S. Patkar Marg, Girgaum Chowpatty, Mumbai 400 007. Tel: (022) 66188800 / Fax: (022) 66188899 e-mail: research@indianivesh.in | Website: www.indianivesh.in Disclaimer: This document has been prepared by IndiaNivesh Securities Private Limited (“INSPL”), for use by the recipient as information only and is not for circulation or public distribution. INSPL includes subsidiaries, group and associate companies, promoters, employees and affiliates. INSPL researches, aggregates and faithfully reproduces information available in public domain and other sources, considered to be reliable and makes them available for the recipient, though its accuracy or completeness has not been verified by INSPL independently and cannot be guaranteed. The third party research material included in this document does not represent the views of INSPL and/or its officers, employees and the recipient must exercise independent judgement with regard to such content. This document has been published in accordance with the provisions of Regulation 18 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. This document is not to be altered, transmitted, reproduced, copied, redistributed, uploaded or published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from INSPL. This document is solely for information purpose and should not to be construed as an offer to sell or the solicitation of an offer to buy any security. Recipients of this document should be aware that past performance is not necessarily a guide for future performance and price and value of investments can go up or down. The suitability or otherwise of any investments will depend upon the recipients particular circumstances. INSPL does not take responsibility thereof. The research analysts of INSPL have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. This document is based on technical and derivative analysis center on studying charts of a stock’s price movement, outstanding positions and trading volume, as opposed to focusing on a company’s fundamentals and, as such, may not match with a report on a company’s fundamentals. Nothing in this document constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances. INSPL does not accept any responsibility or whatever nature for the information, assurances, statements and opinion given, made available or expressed herein or for any omission or for any liability arising from the use of this document. Opinions expressed are our current opinions as of the date appearing on this document only. The opinions are subject to change without any notice. INSPL directors/employees and its clients may have holdings in the stocks mentioned in the document. This report is based / focused on fundamentals of the Company and forward-looking statements as such, may not match with a report on a company’s technical analysis report Each of the analysts named below hereby certifies that, with respect to each subject company and its securities for which the analyst is responsible in this report, (1) all of the views expressed in this report accurately reflect his or her personal views about the subject companies and securities, and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this report: Daljeet S Kohli, Amar Maurya, Abhishek Jain, Yogesh Hotwani, Prerna Jhunjhunwala, Kaushal Patel, Rahul Koli, Tushar Manudhane & Dharmesh Kant. Following table contains the disclosure of interest in order to adhere to utmost transparency in the matter: INSPL, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictoryto the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. INSPL reserves the right to make modifications and alternations to this statement, as may be required, from time to time. Definitions of ratings BUY. We expect this stock to deliver more than 15% returns over the next 12 months. HOLD. We expect this stock to deliver -15% to +15% returns over the next 12 months. SELL. We expect this stock to deliver <-15% returns over the next 12 months. Our target prices are on a 12-month horizon basis. Other definitions NR = Not Rated. The investment rating and target price, if any, have been arrived at due to certain circumstances not in control of INSPL CS = Coverage Suspended. INSPL has suspended coverage of this company. UR=Under Review. Such e invest review happens when any developments have already occurred or likely to occur in target company & INSPL analyst is waiting for some more information to draw conclusion on rating/target. NA = Not Available or Not Applicable. The information is not available for display or is not applicable. NM = Not Meaningful. The information is not meaningful and is therefore excluded. Research Analyst has not served as an officer, director or employee of Subject Company One year Price history of the daily closing price of the securities covered in this note is available at www.nseindia.com and www.economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose name of company in the list browse companies and select 1 year in icon YTD in the price chart) Home Disclosure of Interest Statement 1. Details of business activity of IndiaNivesh Securities Private Limited (INSPL) INSPL is a Stock Broker registered with BSE, NSE and MCX - SX in all the major segments viz. Cash, F & O and CDS segments. INSPL is also a Depository Participant and registered with both Depository viz. CDSL and NSDL. Further, INSPL is a Registered Portfolio Manager and is registered with SEBI. 2. Details of Disciplinary History of INSPL No disciplinary action is / was running / initiated against INSPL 3. Details of Associates of INSPL 4. Research analyst or INSPL or its relatives'/associates' financial interest in the subject No (except to the extent of shares held by Research analyst or INSPL or its relatives'/associates') company and nature of such financial interest 5. Research analyst or INSPL or its relatives'/associates' actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document. 6. Research analyst or INSPL or its relatives'/associates' any other material conflict of interest at the time of publication of the document No 7. Has research analyst or INSPL or its associates received any compensation from the subject company in the past 12 months No 8. Has research analyst or INSPL or its associates managed or co-managed public offering of securities for the subject company in the past 12 months No 9. Has research analyst or INSPL or its associates received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months No 10. Has research analyst or INSPL or its associates received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months No 11. Has research analyst or INSPL or its associates received any compensation or other benefits from the subject company or third party in connection with the document. No 12. Has research analyst served as an officer, director or employee of the subject company No 13. Has research analyst or INSPL engaged in market making activity for the subject company No 14. Other disclosures No Please refer to the important 'Stock Holding Disclosure' report on the IndiaNivesh website (investment Research Section - http://www.indianivesh.in/Research/Holding_Disclosure.aspx?id=10link). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. INSPL and its affiliates may have investment positions in the stocks recommended in this report. Please refer to the important 'Stock Holding Disclosure' report on the IndiaNivesh website (investment Research Section - http://www.indianivesh.in/Research/Holding_Disclosure.aspx?id=10link). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. INSPL and its affiliates may have investment positions in the stocks recommended in this report.